-
1
-
-
0025164639
-
Spontaneous tumors in dogs and cats: Models for the study of cancer biology and treatment
-
MacEwen EG. Spontaneous tumors in dogs and cats: models for the study of cancer biology and treatment. Cancer Metastasis Rev 1990; 9:125-136.
-
(1990)
Cancer Metastasis Rev
, vol.9
, pp. 125-136
-
-
MacEwen, E.G.1
-
2
-
-
0029130028
-
The expression of P-glycoprotein in canine lymphoma and its association with multi-drug resistance
-
Moore A, Leveille C, Reimann K, et al. The expression of P-glycoprotein in canine lymphoma and its association with multi-drug resistance. Cancer Invest 1995;13:475-479.
-
(1995)
Cancer Invest
, vol.13
, pp. 475-479
-
-
Moore, A.1
Leveille, C.2
Reimann, K.3
-
3
-
-
0033637297
-
Modulation of P-glycoprotein-mediated doxorubicin resistance in canine cell lines
-
Page RL, Hughes C, Huyan S, et al. Modulation of P-glycoprotein-mediated doxorubicin resistance in canine cell lines. Anti-cancer Res 2000;20:3533-3538.
-
(2000)
Anti-cancer Res
, vol.20
, pp. 3533-3538
-
-
Page, R.L.1
Hughes, C.2
Huyan, S.3
-
4
-
-
0013415075
-
Hematopoietic tumors
-
Ettinger SJ, Feldman EC, eds, 5th ed. Philadelphia: WB Saunders Co
-
Vail DM. Hematopoietic tumors. In: Ettinger SJ, Feldman EC, eds. Textbook of veterinary internal medicine. 5th ed. Philadelphia: WB Saunders Co, 2000;507-523.
-
(2000)
Textbook of veterinary internal medicine
, pp. 507-523
-
-
Vail, D.M.1
-
5
-
-
0037358040
-
Overcoming multidrug resistance in cancer: An update on the clinical strategy of inhibiting P-glycoprotein
-
Thomas H, Coley H. Overcoming multidrug resistance in cancer: an update on the clinical strategy of inhibiting P-glycoprotein. Cancer Causes Control 2003;10:159-165.
-
(2003)
Cancer Causes Control
, vol.10
, pp. 159-165
-
-
Thomas, H.1
Coley, H.2
-
6
-
-
0035793123
-
Sequencing and tissue distribution of the canine MRP2 gene compared with MRP1 and MDR1
-
Conrad S, Vietelhaus A, Orzechowski A, et al. Sequencing and tissue distribution of the canine MRP2 gene compared with MRP1 and MDR1. Toxicology 2000;156:81-91.
-
(2000)
Toxicology
, vol.156
, pp. 81-91
-
-
Conrad, S.1
Vietelhaus, A.2
Orzechowski, A.3
-
7
-
-
0345299165
-
Drug resistance and ATP-dependent conjugate transport mediated by the apical multidrug resistance protein, MRP2, permanently expressed in human and canine cells
-
Cui Y, Konig J, Buchholz J, et al. Drug resistance and ATP-dependent conjugate transport mediated by the apical multidrug resistance protein, MRP2, permanently expressed in human and canine cells. Mol Pharmacol 1999;55:929-937.
-
(1999)
Mol Pharmacol
, vol.55
, pp. 929-937
-
-
Cui, Y.1
Konig, J.2
Buchholz, J.3
-
8
-
-
3543068267
-
Quantification of MDR-1 gene expression in canine tissues by real-time reverse transcriptase quantitative polymerase chain reaction
-
Culmsee K, Gruber A, Von Samson-Himmerlstjerna G, et al. Quantification of MDR-1 gene expression in canine tissues by real-time reverse transcriptase quantitative polymerase chain reaction. Res Vet Sci 2004;77:223-229.
-
(2004)
Res Vet Sci
, vol.77
, pp. 223-229
-
-
Culmsee, K.1
Gruber, A.2
Von Samson-Himmerlstjerna, G.3
-
9
-
-
0030227521
-
Immunohistochemical detection of P-glycoprotein in formalin-fixed and paraffin-embedded normal and neoplastic canine tissues
-
Ginn PE. Immunohistochemical detection of P-glycoprotein in formalin-fixed and paraffin-embedded normal and neoplastic canine tissues. Vet Pathol 1996;33:533-541.
-
(1996)
Vet Pathol
, vol.33
, pp. 533-541
-
-
Ginn, P.E.1
-
10
-
-
33847201406
-
Dexamethasone treatment of a canine, but not human, tumor cell line increases chemoresistance independent of P-glycoprotein and multidrug resistance-related protein expression
-
Mealey KL, Bentjen S, Gay J, et al. Dexamethasone treatment of a canine, but not human, tumor cell line increases chemoresistance independent of P-glycoprotein and multidrug resistance-related protein expression. Vet Comp Oncol 2003;1:67-75.
-
(2003)
Vet Comp Oncol
, vol.1
, pp. 67-75
-
-
Mealey, K.L.1
Bentjen, S.2
Gay, J.3
-
11
-
-
0033897693
-
P-glycoprotein and multidrug resistance protein activities in relation to treatment outcome in acute myeloid leukemia
-
van der Kolk D, de Vries E, van Putten W, et al. P-glycoprotein and multidrug resistance protein activities in relation to treatment outcome in acute myeloid leukemia. Clin Cancer Res 2000;6:3205-3214.
-
(2000)
Clin Cancer Res
, vol.6
, pp. 3205-3214
-
-
van der Kolk, D.1
de Vries, E.2
van Putten, W.3
-
12
-
-
0037704286
-
Identification and characterization of the canine multidrug resistance-associated protein
-
Ma L, Pratt S, Cao J, et al. Identification and characterization of the canine multidrug resistance-associated protein. Mol Cancer Ther 2002;1:1335-1342.
-
(2002)
Mol Cancer Ther
, vol.1
, pp. 1335-1342
-
-
Ma, L.1
Pratt, S.2
Cao, J.3
-
13
-
-
0029965253
-
P-glycoprotein expression in canine lymphoma: A relevant, intermediate model of multidrug resistance
-
Lee J, Hughes C, Fine R, et al. P-glycoprotein expression in canine lymphoma: a relevant, intermediate model of multidrug resistance. Cancer 1996;77:1892-1898.
-
(1996)
Cancer
, vol.77
, pp. 1892-1898
-
-
Lee, J.1
Hughes, C.2
Fine, R.3
-
14
-
-
0030278180
-
Monoclonal antibody C219. Immunohistochemistry against P-glycoprotein: Sequential analysis and predictive ability in dogs with lymphoma
-
Bergman P, Ogilvie G, Powers B. Monoclonal antibody C219. Immunohistochemistry against P-glycoprotein: sequential analysis and predictive ability in dogs with lymphoma. J Vet Intern Med 1996;10:354-359.
-
(1996)
J Vet Intern Med
, vol.10
, pp. 354-359
-
-
Bergman, P.1
Ogilvie, G.2
Powers, B.3
-
15
-
-
0031922587
-
Characterization of canine MDR1 mRNA: Its abundance in drug resistance cell lines and in vivo
-
Steingold SF, Sharp N, McGahan M, et al. Characterization of canine MDR1 mRNA: its abundance in drug resistance cell lines and in vivo. Anticancer Res 1998;18:393-400.
-
(1998)
Anticancer Res
, vol.18
, pp. 393-400
-
-
Steingold, S.F.1
Sharp, N.2
McGahan, M.3
-
16
-
-
0345643354
-
Functional analysis of P-glycoprotein and multidrug resistance associated protein related multidrug resistance in AML-blasts
-
Brugger D, Herbart H, Gekeler V, et al. Functional analysis of P-glycoprotein and multidrug resistance associated protein related multidrug resistance in AML-blasts. Leuk Res 1999;23:467-475.
-
(1999)
Leuk Res
, vol.23
, pp. 467-475
-
-
Brugger, D.1
Herbart, H.2
Gekeler, V.3
-
17
-
-
2142648906
-
Evaluation and comparison of MRP1 activity with three fluorescent dyes and three modulators in leukemia cell lines
-
Dogan A, Legrand O, Faussat A-M, et al. Evaluation and comparison of MRP1 activity with three fluorescent dyes and three modulators in leukemia cell lines. Leuk Res 2004;28:619-622.
-
(2004)
Leuk Res
, vol.28
, pp. 619-622
-
-
Dogan, A.1
Legrand, O.2
Faussat, A.-M.3
-
18
-
-
0033555758
-
P-glycoprotein expression on normal and abnormal expanded natural killer cells and inhibition of p-glycoprotein function with cyclosporine A and its analogue, PSC833
-
Egashira M, Kawamata N, Sugimoto K, et al. P-glycoprotein expression on normal and abnormal expanded natural killer cells and inhibition of p-glycoprotein function with cyclosporine A and its analogue, PSC833. Blood 1999;93:559-606.
-
(1999)
Blood
, vol.93
, pp. 559-606
-
-
Egashira, M.1
Kawamata, N.2
Sugimoto, K.3
-
19
-
-
0033192626
-
Use of the anionic dye carboxy-2′, 7′-clichlorofluorescein for sensitive flow cytometric detection of multidrug resistance-associated protein activity
-
Laupeze B, Amiot L, Courtois A, et al. Use of the anionic dye carboxy-2′, 7′-clichlorofluorescein for sensitive flow cytometric detection of multidrug resistance-associated protein activity. Int J Oncol 1999;15:571-576.
-
(1999)
Int J Oncol
, vol.15
, pp. 571-576
-
-
Laupeze, B.1
Amiot, L.2
Courtois, A.3
-
20
-
-
0036538694
-
Determination of P-gp and MRP1 expression and function in peripheral blood mononuclear cells in vivo
-
Meaden E, Hoggard P, Khoo S, et al. Determination of P-gp and MRP1 expression and function in peripheral blood mononuclear cells in vivo. J Immunol Methods 2002;262:159-165.
-
(2002)
J Immunol Methods
, vol.262
, pp. 159-165
-
-
Meaden, E.1
Hoggard, P.2
Khoo, S.3
-
21
-
-
0043239277
-
Single-cell image analysis to assess ABC-transporter-mediated efflux in highly purified hematopoietic progenitors
-
Rhaaijimakers H, van den Bosch G, Boezeman J, et al. Single-cell image analysis to assess ABC-transporter-mediated efflux in highly purified hematopoietic progenitors. Cytometry 2002;49:135-142.
-
(2002)
Cytometry
, vol.49
, pp. 135-142
-
-
Rhaaijimakers, H.1
van den Bosch, G.2
Boezeman, J.3
-
22
-
-
0030977630
-
Multidrug resistance-associated protein: A protein distinct from P-glycoprotein involved in cytotoxic drug expulsion
-
Barrand MA, Bagrij T, Neo SY. Multidrug resistance-associated protein: a protein distinct from P-glycoprotein involved in cytotoxic drug expulsion. Gen Pharmacol 1997;28:639-645.
-
(1997)
Gen Pharmacol
, vol.28
, pp. 639-645
-
-
Barrand, M.A.1
Bagrij, T.2
Neo, S.Y.3
-
23
-
-
34547189233
-
Interaction of positional isomers of quercetin glucuronides with the transporter ABCC2 (cMOAT, MRP2)
-
Williamson G, Aeberli I, Miguet L, et al. Interaction of positional isomers of quercetin glucuronides with the transporter ABCC2 (cMOAT, MRP2). Drug Metab Dispos 2007;35:1262-1268.
-
(2007)
Drug Metab Dispos
, vol.35
, pp. 1262-1268
-
-
Williamson, G.1
Aeberli, I.2
Miguet, L.3
-
24
-
-
0028986245
-
-
Gekeler V, Ise W, Sanders KH, eL al. The leukotriene LTD4 receptor antagonist MK571 specifically modulates MRP associated multidrug resistance. Biochem Biophys Res Commun 1995;208:345-352.
-
Gekeler V, Ise W, Sanders KH, eL al. The leukotriene LTD4 receptor antagonist MK571 specifically modulates MRP associated multidrug resistance. Biochem Biophys Res Commun 1995;208:345-352.
-
-
-
-
26
-
-
0030963140
-
Immunophenotypic characterization of canine lymphoproliferative disorders
-
Ruslander D, Gebhard D, Tompkins M, et al. Immunophenotypic characterization of canine lymphoproliferative disorders. In Vivo 1997;11:169-172.
-
(1997)
In Vivo
, vol.11
, pp. 169-172
-
-
Ruslander, D.1
Gebhard, D.2
Tompkins, M.3
|